Company Analysis

Tempest Therapeutics, Inc. (TPST)

Nasdaq: TPST · Pharmaceutical Preparations · Brisbane, CA · filing with the SEC since 2012
Grade3.1
◀ Past 3.5● Present 1.6▶ Future 4.1
3 est.

Income statement, as filed

In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017Dec 31, 2016
Report filedMar 30, 2026Mar 27, 2025Mar 19, 2024Mar 22, 2023Mar 29, 2022Mar 29, 2021Mar 11, 2020Apr 1, 2019Mar 15, 2018Mar 2, 2017
Revenue········295653
Cost of revenue········7905,401
Research and development12,60628,47617,49822,52717,16614,389r27,84314,42514,52621,641
Selling, general and administrative········27,74449,223
General and administrative13,96913,55011,65912,1139,8204,909r17,5568,6915,956·
Total operating expenses········50,90181,665
Operating income-26,575-42,026-29,157-34,640-26,986-19,298r-45,399-26,874-84,326r-81,012
Interest expense2071,3161,4491,6181,2820·134288·
Interest and investment income········752659
Interest income (expense), net·····1551,038-134··
Share of profit of equity-method investments········-1,018-1,542
Other income (expense), net5201,4991,115549-3490··-36-164
Total non-operating income (expense)313183-334-1,069-1,31690····
Income before income taxes········-50,908-82,059
Income tax expense000000··67201
Net income including non-controlling interests-26,262-41,843-29,491-35,709-28,302-19,208r-44,568-27,177-84,586·
Net income to non-controlling interests······015-8·
Net income-26,262-41,843-29,491-35,709-28,302-19,208r-44,568-27,192-84,578r-82,260
Net income to common shareholders········-50,975-82,260
Earnings per share, basic-6.33-19.50r-24.83b-40.17b-97.11b-533.39b····
Earnings per share, diluted-6.33-19.50r-24.83b-40.17b-97.11b-533.39b····
Earnings per share, basic and diluted·····-25.09b-42.25b-228.54b-4,183.53rb-33.28b
Weighted average shares, basic4,149,7332,146,276r1,185,862b888,377b291,562b36,012b····
Weighted average shares, diluted4,149,7332,146,276r1,185,862b888,377b291,562b36,012b····
Weighted average shares, basic and diluted·····1,450,964b1,054,365b119,004b20,217rb2,472,923b
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 1-for-13 reverse split.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it soldus-gaap:Revenues
Cost of revenue what it cost to make or buy what it soldus-gaap:CostOfRevenue
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
us-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative the cost of selling and of running the companyus-gaap:SellingGeneralAndAdministrativeExpense
General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense
Total operating expenses the running costs togetherus-gaap:OperatingExpenses
Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss
Interest expense what its borrowing costus-gaap:InterestExpenseNonoperating
us-gaap:InterestExpense
Interest and investment income what its cash and investments earnedus-gaap:InvestmentIncomeNet
Interest income (expense), net interest earned less interest paid, outside the businessus-gaap:InterestIncomeExpenseNonoperatingNet
Share of profit of equity-method investments its share of companies it partly ownsus-gaap:IncomeLossFromEquityMethodInvestments
Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense
Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense
Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit
Net income including non-controlling interests the whole group's profit, minority holders' share includedus-gaap:ProfitLoss
Net income to non-controlling interests the share that belongs to minority holdersus-gaap:NetIncomeLossAttributableToNoncontrollingInterest
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Net income to common shareholders what is left for common shareholdersus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Earnings per share, basic and diluted net income per share, where both counts are the sameus-gaap:EarningsPerShareBasicAndDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Weighted average shares, basic and diluted the average count, where both counts are the sameus-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
SI Assistanton TPST · research, not advice